TrialClinical drug investigation2024

An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.

David P Walling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.